The third extension of the deal outside date and an almost doubling of the working capital loan limit indicate ongoing complexity and cost in closing the ONE Nuclear combination. Monitor shareholder vote turnout and redemption levels closely as the proxy statement is mailed; a high redemption rate could further pressure deal economics or require additional amendments.
Price Chart
Executive Summary
Hennessy Capital Investment Corp. VII (HVII) and ONE Nuclear Energy LLC have executed Third Omnibus Amendment No. 3 to extend the outside date for their business combination from August 15, 2026 to September 30, 2026, and to increase the maximum principal amount of loan advances under the promissory note from $316,975 to $620,000. This marks the third extension of the deal deadline, signaling continued execution risk and the need for additional working capital to fund transaction expenses. The SEC declared the related S-4 registration statement effective on August 3, 2026, with a definitive proxy statement now being mailed to shareholders of record as of July 31, 2026.
Key Financial Metrics
Key Facts
- Third amendment extends the outside date for the business combination from August 15, 2026 to September 30, 2026.
- Promissory note maturity date proportionally extended from August 15, 2026 to September 30, 2026.
- Maximum aggregate principal amount of loan advances increased from $316,975 to $620,000.
- SEC declared the Form S-4 registration statement effective on August 3, 2026.
- Definitive proxy statement has been filed and is being mailed to HVII shareholders of record as of July 31, 2026.
- This is the third omnibus amendment, following prior amendments on March 31, 2026 and June 1, 2026.
Financial Impact
Promissory note limit raised by approximately $303,025 to $620,000; deal extension suggests incremental operating/transaction costs without disclosed revenue or profitability figures.
Risk Factors
- Failure to close by September 30, 2026 could result in deal termination.
- Increased loan advances signal higher transaction costs, potentially reducing trust value for non-redeeming shareholders.
- Regulatory or shareholder approval risks remain unaddressed despite effective S-4.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001493152-26-036765 |
| Exhibit: ex2-1.htm | 0001493152-26-036765 |
| Document: 0001493152-26-036765-index-headers.html | 0001493152-26-036765 |
| Document: 0001493152-26-036765-index.html | 0001493152-26-036765 |
| Document: 0001493152-26-036765.txt | 0001493152-26-036765 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 3 | $2.15 $1.33 | ▼ −38.14% | ▼ −38.11% | $1.25 (−41.86%) |
Sep 23, 2026 4w ago | 8-K | $3.47 $1.31 | ▼ −62.25% | ▼ −61.83% | $1.25 (−63.98%) |
Sep 22, 2026 5w ago | 425 | $9.08 $1.33 | ▼ −85.35% | ▼ −84.79% | $1.25 (−86.23%) |
Sep 22, 2026 5w ago | 8-K | $9.08 $1.33 | ▼ −85.35% | ▼ −84.79% | $1.25 (−86.23%) |
Sep 14, 2026 6w ago | 425 | $9.54 $1.68 | ▼ −82.39% | ▼ −85.37% | $1.25 (−86.90%) |
Sep 9, 2026 6w ago | 425 | $10.80 | awaiting T+20 | — | $1.25 (−88.43%) |
Aug 31, 2026 8w ago | 425 | $7.89 | awaiting T+20 | — | $1.25 (−84.16%) |
Aug 25, 2026 9w ago | 425 | $7.84 $4.46 | ▼ −43.11% | ▼ −44.09% | $1.25 (−84.06%) |
Aug 19, 2026 9w ago | 425 | $10.53 $10.75 | ▲ +2.14% | ▲ +4.09% | $1.25 (−88.12%) |
Aug 18, 2026 10w ago | 425 | $10.52 $9.80 | ▼ −6.84% | ▼ −5.85% | $1.25 (−88.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers